CyLogic CyCloud Achieves FedRAMP High Ready Status
CyLogic's Secure Enterprise Cloud platform, CyCloud, delivers DoD-level security, compliance, and control for Federal clouds, government contractors, and enterprises requiring the highest level of security
Chevy Chase, Maryland--(Newsfile Corp. - March 5, 2025) - CyLogic, the security-first enterprise cloud company, today announced that its flagship offering, CyCloud, has achieved FedRAMP High Ready designation by the Federal Risk and Authorization Management Program (FedRAMP). This milestone is the result of months of rigorous security assessments conducted by FedRAMP-recognized third-party assessment organization (3PAO) Fortreum. Achieving FedRAMP High Ready status underscores CyLogic's commitment to ensuring that federal agencies, government contractors, and businesses working in the cloud can benefit from the highest level of data protection and control available. This is the fourth consecutive assessment cycle in which CyLogic has achieved this designation.
'We're proud to celebrate this major accomplishment with the dedicated experts at CyLogic who've worked tirelessly to develop CyCloud,' said Louis Mayberg, CEO of CyLogic. 'The FedRAMP designation represents another important step we've taken over the past year to build the most secure cloud platform available to support and protect the way government contractors, federal agencies, and enterprises work today.'
CyCloud is now available on the FedRAMP Marketplace. It offers the ease of use and scalability of a public cloud, the security controls and cost predictability of a private cloud, and, with its FedRAMP High Ready designation, a higher level of security than any public cloud provider. CyCloud's FedRAMP High Ready platform delivers data security controls that exceed current regulatory requirements such as PCI, NIST, CMMC, HIPAA, and more. CyCloud is a self-service cloud infrastructure, built on VMWare Cloud Foundation, that scales to support and protect business-critical applications and data. CyCloud integrates leading technologies at the highest US government security standards.
About CyLogic
CyLogic builds, operates, and continuously monitors cloud offerings for enterprises and government contractors requiring the highest level of security, compliance, and control over sensitive data. CyLogic's unrivaled compliance and data security solutions protect digital assets whether they're in the cloud, on-premises, or on edge devices. CyLogic is the creator of CyCloud, a FedRAMP High-Ready cloud solution for the public and commercial sectors. Built on VMware Cloud Foundation (VCF) software, Dell Technologies TAA-compliant hardware, and Equinix data centers, CyCloud combines the simplicity and scalability of a public cloud with the most rigorous cybersecurity requirements of a DoD-level private cloud. CyLogic's Cyber Platform delivers rapid security posture enhancement with top-tier data protection and resilience to small and medium organizations interested in storing, managing, and accessing data from a security-first perspective.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
PreveCeutical Announces Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 15,000,000 units in the capital of the Company (the "Units") at a price of $0.05 per Unit for gross proceeds of up to $750,000. Each Unit consists of one (1) common share of the Company (each, a "Share") and one-half (1/2) of one Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant entitles the holder thereof to purchase an additional Share (each, a "Warrant Share") at an exercise price of $0.08 per Warrant Share for a period of 24 months from the closing of the Offering (the "Closing"); provided that the expiry of the Warrants can be accelerated if the closing price of the Company's common shares on the Canadian Securities Exchange (the "CSE") is $0.10 or greater for a minimum of ten consecutive trading days, and a notice of acceleration is provided in accordance with the terms of the Warrants. Finder's fees may be paid. The Company intends to use the aggregate gross proceeds from the sale of the Offering to pay outstanding payables, for operating expenses and for general working capital purposes. All securities issued in connection with the Offering will be subject to a statutory hold period expiring four months and one day after the Closing. Completion of the Offering remains subject to certain conditions, including, without limitation, confirmation of no objection from the CSE. The securities issued under the Offering will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About PreveCeutical PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical aims to be a leader in preventive health sciences and currently has five research and development programs, including: dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical™ peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). For more information about PreveCeutical, please visit our website or follow us on Twitter and Facebook. On behalf of the Board of Directors of PreveCeutical, Stephen Van Deventer, Chairman and Chief Executive Officer For further information, please contact: Stephen Van Deventer: +1 604 306 9669 Or Investor Relations ir@ Neither the CSE nor any Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, statements with respect to the expectations of management regarding the proposed Offering, the expectations of management regarding the use of proceeds of the Offering, closing conditions for the Offering, the expiry of hold periods for securities distributed pursuant to the Offering and other statements regarding the company's proposed business plans. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements including that: the Company may not complete the Offering on terms favorable to the Company or at all; the proceeds of the Offering may not be used as stated in this news release; the Company may be unable to satisfy all of the conditions to the Closing; and those additional risks set out in the Company's public documents filed on SEDAR+ at Although the Company believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
Pride at Work Canada Closes the Market
Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - Colin Druhan, Executive Director, Pride at Work Canada/Fierté au travail Canada ("Pride" or "Pride at Work Canada") his team, and a selected group of Community and Proud Partners, joined Dani Cohen, Head of Talent and Organizational Development, Human Resources, TMX Group, to close the market to celebrate Pride Month. Cannot view this video? Visit: This meaningful event reflects the growing recognition that uplifting 2SLGBTQIA+ human rights in the workplace is not just a matter of equity, but a strategic business imperative. By championing welcoming cultures, employers empower current and future talent to thrive authentically. With a national network of over 250 Proud Partners, Pride at Work Canada demonstrates that organizations across sectors are not only celebrating Pride, but actively working year-round to build safer, more inclusive, and equitable workplaces for all. The vision that Pride at Work Canada shares with their employer members is a Canada where every individual can achieve their full potential at work, regardless of gender expression, gender identity, and sexual orientation. MEDIA CONTACT:Andrew PerezMedia Contactandrew@ To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Denarius Metals Announces Voting Results of the Annual General and Special Meeting of Shareholders Held Today
Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) ("Denarius Metals" or "the Company") is pleased to announce the voting results of the Annual General and Special Meeting of Shareholders held today. Shareholders holding 56,914,696 shares, being 52.09% of the outstanding shares of the Company as at the record date, were represented by proxy at the meeting. The detailed results of the votes for each matter acted upon are set out below: Item Description of Matter Outcome Voted Voted (%) 1. Fixing the number of directors at six Approved For 56,724,120Against 190,575 99.67%0.33% 2. The election of the following individuals as directors of the Company to hold office until the next annual meeting of the Company or until their successors are appointed or elected: Serafino Iacono Approved For 54,337,668Withheld 35,600 99.94%0.06%Federico Restrepo-Solano Approved For 54,318,869Withheld 54,399 99.90%0.10%Paul Sparkes Approved For 54,327,068Withheld 46,200 99.92%0.08%Mateo Restrepo Villegas Approved For 54,327,068Withheld 46,200 99.92%0.08%Francisco Sole Approved For 54,343,768Withheld 29,500 99.95%0.05%Patricia Herrera Paba Approved For 54,339,269Withheld 33,999 99.94%0.06% 3. Appointment of KPMG LLP as auditors of the Company at a remuneration to be fixed by the directors Approved For 56,908,196Withheld 6,500 99.99%0.01% About Denarius Metals Denarius Metals is a Canadian junior company engaged in the acquisition, exploration, development and eventual operation of precious metals and polymetallic mining projects in high-grade districts in Colombia and Spain. Denarius Metals is listed on Cboe Canada where it trades under the symbol "DMET". The Company also trades on the OTCQX Market in the United States under the symbol "DNRSF". In Colombia, Denarius Metals recently commenced mining operations at its 100%-owned Zancudo Project, a high-grade gold-silver deposit, which includes the historic producing Independencia mine, located in the Cauca Belt, about 30 km southwest of Medellin. In Spain, Denarius Metals has interests in three projects focused on in-demand critical minerals. The Company owns a 21% interest in Rio Narcea Recursos, S.L. and is the operator of its Aguablanca Project, which has recently been recognized by the EU as a Strategic Project. The Aguablanca Project comprises a turnkey 5,000 tonnes per day processing plant and the rights to exploit the historic producing Aguablanca nickel-copper mine, located in Monesterio, Extremadura. Denarius Metals also owns a 100% interest in the Lomero Project, a polymetallic deposit located on the Spanish side of the prolific copper rich Iberian Pyrite Belt, approximately 88 km southwest of the Aguablanca Project, and a 100% interest in the Toral Project, a high-grade zinc-lead-silver deposit located in the Leon Province, Northern Spain. Additional information on Denarius Metals can be found on its website at and by reviewing its profile on SEDAR+ at Cautionary Statement on Forward-Looking Information This news release contains "forward-looking information", which may include, but is not limited to, statements with respect to anticipated business plans or strategies. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Denarius Metals to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in the Company's Annual Information Form dated March 31, 2025 which is available for view on SEDAR+ at Forward-looking statements contained herein are made as of the date of this press release and Denarius Metals disclaims, other than as required by law, any obligation to update any forward-looking statements whether as a result of new information, results, future events, circumstances, or if management's estimates or opinions should change, or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements. For Further Information, Contact: Michael DaviesChief Financial Officer(416) 360-4653investors@ To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
